Ochsner Health announced today that it has become the first healthcare organization in Louisiana to offer Aquablation therapy for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH).
Approximately 90,000 Americans, including 1,100 children are currently waiting for a kidney transplant. Tragically, 12 Americans will die today waiting for a kidney. Advocates from the American Society of Nephrology (ASN) are on Capitol Hill today urging Congress to implement reforms that will help maximize access to transplant care for the 37 million Americans living with kidney diseases; the 8th leading cause of death in the United States.
Urotronic, Inc., a Minnesota-based medical device company pioneering the application of its drug-coated balloon technologies for use in interventional urology, today announced the world's first commercial procedure of the Optilume BPH® Catheter System to treat benign prostatic hyperplasia (BPH) was completed by Dr. Dean Elterman, urologist at University Urology Associates, in Toronto, Canada.
Fiscal year 2023, which ended June 30, proved to be the busiest year yet for Cedars-Sinai’s Comprehensive Transplant Center and Smidt Heart Institute, with more than 600 organs transplanted.
Artificial intelligence is becoming increasingly important in drug discovery.
Patients who engage in light exercise while undergoing dialysis are physically fitter and are admitted to hospital less frequently than those who do not.
Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a rare hereditary syndrome that increases the risk of kidney cancer.
When an ill person schedules a doctor visit, blood work or other diagnostic testing is often required before a diagnosis is determined. Missouri University of Science and Technology electrical engineering researcher Dr. Jie Huang is developing technology that would allow patients to “just breathe” and avoid that testing.
Prof. Pol.Capt. Pharm. Dr. Suchada Sukrong, lecturer at the Faculty of Pharmaceutical Sciences and a researcher at the Center of Excellence in DNA Barcoding of Thai Medicinal Plants, Chulalongkorn University, Dr. Kannika Thongkhao, and Pharm. Chayaphol Tangpatthong have won the gold medal and two Special Awards, namely the FIRI Award in the Best Invention category from “The first institute of inventors and researchers of Iran” (FIRI), Iran, and a Special Awards from “The Industrial Property Office of the Czech Republic the Czech Metallurgical Society,” The Czech Republic, in The 16th International Invention and Innovation Show (INTARG 2023) on May 24-25, 2023, at Katowice International Conference Center, Katowice, Republic of Poland, with their “Rapid DNA immunochromatographic assay for detection of toxic Aristolochia species, the plants responsible for aristolochic acid nephropathy”.
In a study led by Johns Hopkins Medicine, in collaboration with Yale School of Medicine, researchers have identified a biomarker found via a simple urine test that can be used to diagnose acute tubulointerstitial nephritis (AIN), a medical condition that causes inflammation of the kidneys and can lead to acute kidney injury (AKI) — a sudden loss of kidney function. Experts say a kidney biopsy is often required to diagnose AIN because there are no disease-specific signs or symptoms.
KidneyCure (the ASN Foundation) is honored to continue its support of investigators committed to advancing kidney health. Building on decades of success, KidneyCure makes it possible to improve knowledge and treatment by identifying and funding high-impact projects. Investigators funded by KidneyCure are making a difference in key areas that impact care for millions. KidneyCure is proud to support excellence and innovation, and to extend the advances that the foundation has propelled since its inception.
A new study finds that the minimum level of oxygen delivery during cardiopulmonary bypass may be lower than previously thought — meaning, there may be opportunities to avoid transfusing patients during cardiac surgical procedures. Researchers say cardiac surgical programs may be unnecessarily transfusing patients to prevent kidney injury.
Today, AACC—in collaboration with the National Kidney Foundation (NKF)—released guidance to reduce racial and gender disparities in the care of patients with chronic kidney disease (CKD). The document gives members of the healthcare team actionable, evidence-based tools to improve equity in kidney health, including recommendations for using an updated algorithm that does not disproportionately affect any one group of individuals.
Researchers at The University of Texas MD Anderson Cancer have engineered a new model of aggressive renal cell carcinoma (RCC), highlighting molecular targets and genomic events that trigger chromosomal instability and drive metastatic progression. The study, published today in Nature Cancer, demonstrates that the loss of a cluster of interferon receptor (IFNR) genes plays a pivotal role in allowing cancer cells to become tolerant of chromosomal instability. This genomic feature may be used to help clinicians predict a tumor’s potential to become metastatic and treatment resistant.
Renal cell carcinoma is the most common form of kidney cancer. To treat metastatic renal cancer, combinations of immunotherapies are used as the first line of treatment.
Loyola Medicine's advanced robotic surgery program makes it one of the few hospitals in the country to offer kidney transplantation to patients with obesity.
The new devices reduce recovery times. Innovative techniques may reduce them more.
Mortality in patients with kidney failure has been found to be 23% lower among those treated with high dose haemodiafiltration compared to those treated with high flux haemodialysis, according to new research from the CONVINCE consortium led by University Medical Center Utrecht.
The painful experience of having a kidney stone has become more common in recent years, including in Texas, part of the “Stone Belt” where hot weather can cause dehydration. But small dietary changes as well as drinking lots of water can help avert the discomfort, says a board-certified physician assistant in the Department of Urology at UT Southwestern Medical Center.
Today, the Kidney Innovation Accelerator (KidneyX), a public private partnership between the American Society of Nephrology (ASN) and the US Department of Health and Human Services (HHS) announced the eight winners of the Artificial Kidney Prize Phase 2 at the KidneyX Summit in Washington, DC. The competition recognized participants’ innovative approaches to developing a bioartificial kidney and was divided into two tracks with two Track 1 participants each receiving $1,600,000, and six Track 2 participants each receiving $1,000,000.
Fatigue is the symptom that most significantly impacts the daily lives of long Covid patients, and can affect quality of life more than some cancers, finds a new study led by researchers at UCL and the University of Exeter.
Some centers routinely skip the top kidney transplant candidates on the wait list and give the kidney to lower-ranked patients, finds a new study at Columbia University.
La insuficiencia renal puede tener diversas causas: diabetes, presión arterial alta, enfermedades autoinmunitarias y enfermedad renal poliquística o ERP.
A insuficiência renal pode ser causada por diversos motivos: diabetes, pressão arterial elevada, doenças autoimunes e doença renal policística ou DRP.
قد ينتج الفشل الكلوي عن عدة أسباب منها، السكري وارتفاع ضغط الدم، وأمراض المناعة الذاتية، وداء الكلى متعددة الكيسات.
Cedars-Sinai clinicians and scientists, including Medawar Prize winner Stanley Jordan, MD, and prominent nephrology and immunology investigator Peter Heeger, MD, will share their latest advances in research at the American Transplant Congress (ATC), June 3-7, 2023, in San Diego.
Researchers found that receiving intensive antihypertensive treatment as an inpatient was linked with greater risk of adverse events, particularly for patients receiving the medication intravenously as opposed to orally.
Each year, ASN recognizes individuals who have demonstrated exceptional leadership and achievements in clinical care, education, and research through our lifetime achievement and midcareer awards. Above all, kidney professionals imbue their work with compassion, dedication, and respect for the people whose lives they improve.
The American Society of Nephrology (ASN) announced today that Rajnish Mehrotra, MD, MS, FASN, will be its new Editor-in-Chief of the Journal of the American Society of Nephrology (JASN) and Senior Editor-in-Chief for the ASN Journal Portfolio. Mehrotra’s term will begin January 1, 2024, and continue through December 31, 2029. He currently serves as the Editor-in-Chief of CJASN. The ASN Journal Portfolio includes three monthly journals, JASN, CJASN, and the online-only, open access journal, Kidney360.
Announcement of Zoe Stewart Lewis, MD, PhD, MPH, as the new Director of Cleveland's University Hospitals Transplant Institute and Chief of the Division of Transplant and Hepatobiliary Surgery in the Department of Surgery.
A team of engineers at the University of Colorado Boulder has designed a new class of tiny, self-propelled robots that can zip through liquid at incredible speeds—and may one day even deliver prescription drugs to hard-to-reach places inside the human body.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.
Unfortunately, effective medical therapies do not exist for this population of patients, Dr. Pavan Bhatraju said. In their paper, the investigators proposed a way to classify subpopulations of AKI patients with the aim of identifying therapies specific patient populations.
Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest research and clinical trial results on combination therapies for breast cancer, a potential new treatment for patients with recurrent glioma, and advances in PSMA PET guided radiotherapy for patients with prostate cancer, among other topics, at the American Society of Clinical Oncology’s annual meeting.
The American Society of Nephrology (ASN) applauds the introduction of the Securing the U.S. Organ Procurement and Transplantation Network Act (S. 1668), bipartisan legislation to ensure accountability and transparency in the U.S. transplant system by modernizing its underlying technology and policy infrastructure.
The number of deaths worldwide from ischemic stroke increased from 2 million in 1990 to more than 3 million in 2019, and is expected to increase to nearly 5 million by 2030, according to a study published in the May 17, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study focused on ischemic stroke, which is caused by a blockage of blood flow to the brain and is the most common type of stroke.
Giving people at high risk of PFAS exposure the opportunity to easily self-test could improve access to testing for these “forever chemicals” and lead to the early detection of detrimental health conditions, according to a new Michigan State University study. The study tested an improved approach for people to collect their own blood samples to test for PFAS without being part of an academic research study.
The Wake Forest Institute for Regenerative Medicine (WFIRM) will make history this month when the first bioprinted solid tissue constructs soar to the International Space Station (ISS) on board the next all private astronaut mission by commercial space leader Axiom Space.
Researchers from Sanford Burnham Prebys and the Chinese University of Hong Kong have developed a computational approach to predict whether a person with type 2 diabetes will develop kidney disease. The findings could help doctors prevent or better manage kidney disease in people with type 2 diabetes.
It's one thing to buy your mother flowers or a gift certificate to the spa for Mother’s Day - but it’s a whole other thing to give her the gift of life. In a reversal of roles, thanks to the miracle of kidney donation, a New Jersey daughter was able to give her own mother the gift of life, 37 years after her mom gave her life.
Hackensack Meridian Hackensack University Medical Center’s Department of Urology presented 14 abstracts at the American Urological Association’s (AUA) 2023 Annual Meeting.
A targeted kinase inhibitor added to a two-drug immunotherapy combination slowed the progression of advanced kidney cancer in previously untreated patients, according to research published in The New England Journal of Medicine and led by an oncologist from Dana-Farber Cancer Institute.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
